Show
Sort by
-
Profiling histone post-translational modifications to identify signatures of epigenetic drug response in T-cell acute lymphoblastic leukemia
-
- Journal Article
- A1
- open access
EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines
-
- Journal Article
- A1
- open access
A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia
-
Prime editing outperforms optimized homology-directed repair as a tool for knock-in generation in zebrafish
-
- Journal Article
- A1
- open access
Tet2 is a tumor suppressor in the pre-leukemic phase of T-cell acute lymphoblastic leukemia
-
Towards improved Parsortix® efficiency for circulating tumor cell enrichment in pancreatic cancer
-
Advances in CRISPR-mediated knock-in of disease-related variants in zebrafish
-
Advances in CRISPR-mediated knock-in of disease- and cancer-related variants in zebrafish
-
- Journal Article
- A1
- open access
Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia
-
- Journal Article
- A1
- open access
Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma